Skip to main navigation menu Skip to main content Skip to site footer

Chronic pulmonary histoplasmosis in an immunocompetent adult

Histoplasmosis pulmonar crónica en un adulto inmunocompetente




Section
Presentación de casos

How to Cite
Chronic pulmonary histoplasmosis in an immunocompetent adult.
rev. colomb. neumol. [Internet]. 2018 May 10 [cited 2024 Nov. 24];29(2):67-73. Disponible en: https://doi.org/10.30789/rcneumologia.v29.n2.2017.269

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Ivonne Tatiana Ordóñez Blanco
    Javier Ricardo Garzón Herazo
      Javier Iván Lasso Apráes
        Viviana Cruz Ramírez

          Histoplasmosis is the most common endemic mycosis around the world, increasing proportionally with the growing need of immunosuppressive therapies for the treatment of different diseases. Caused by the microorganism Histoplasma capsulatum, the most frequent clinical form is the pulmonary one, which is classified, according to the time of presentation, inacute, subacute, and chronic. Chronic histoplasmosis accounts for 8% of cases, characterized by the progressive formation of cavities and extensive destruction of the pulmonary parenchyma, typically described in patients with chronic pulmonary disease and smoking history. In Colombia, up to 10% of cases is not associated with risk factors. Given its importance and the scarce information reported in the literature, we present the case of a 50-year-old man treated at Hospital Universitario San Ignacio who was diagnosed with chronic pulmonary histoplasmosis and in whom immunodeficiency studies were normal, identifying themselves as unique factor of risk its occupation as demolisher of constructions.

          Article visits 3311 | PDF visits 5247


          Downloads

          Download data is not yet available.
          1. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin North Am. 2016;30(1):207–27. DOI: 10.1016/j.idc.2015.10.009.
          2. Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, et al. Histoplasmosis: results of the Colombian national survey, 1992-2008. Biomed. 2011;31(3):344-56. DOI: 10.1590/S0120-41572011000300007.
          3. Goodwin RA, Owens FT, Snell JD, Hubbard WW, Buchanan RD, Terry RT, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore). 1976;55(6):413-52.
          4. Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore). 2007;86(4):252-8. DOI: 10.1097/MD.0b013e318144b1d9.
          5. Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med. 2015;36(5):729-45. DOI: 10.1055/s-0035-1562899.
          6. Pometta R, Trovato C, Viviani MA, Masini T, Conte D. Chronic pulmonary histoplasmosis in a patient with a recent history of tuberculosis and persistent round lung lesions. Eur J Clin Microbiol Infect Dis. 1999;18(3):229-31. DOI: https://doi.org/10.1007/s100960050267.
          7. Zöllner MSA, Rezende KMPEC, Birman S, Elias CPF, Arisawa EÂL, Santos MABDV. Clinical and evolutionary characteristics of four patients with pulmonary histoplasmosis reported in the Paraíba Paulista Valley region. Rev Soc Bras Med Trop. 2010;43(5):599-601. DOI: http://dx.doi.org/10.1590/S0037-86822010000500028.
          8. Santos JW, Michel GT, Lazzarotto M, Figaro JK, Spilmann D, Homrich GK. Chronic cavitary pulmonary histoplasmosis. J Bras Pneumol. 2009;35(11):1161–4. DOI: http://dx.doi.org/10.1590/S1806-37132009001100016.
          9. Johnson HE, Batson R. Benign pulmonary histoplasmosis. Dis Chest. 1948;14(4):517-24. DOI: https://doi.org/10.1378/chest.14.4.517.
          10. García-Marrón M, García-García JM, Pajín-Collada M, Alvarez-Navascués F, Martínez-Muñiz MA, Sánchez-Antuña AA. Chronic pulmonary histoplasmosis diagnosed in a nonimmunosuppressed patient 10 years after returning from an endemic area. Arch Bronconeumol. 2008;44(10):567-70. DOI: 10.1157/13126837.
          11. Capone D, Wanke B, Monteiro PC, Lazéra MS, de Noronha Andrade G, do Valle AC, et al. Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil. Mycopathologia. 1999;145(2):75-9. DOI: https://doi.org/10.1023/A:1007016414833.
          12. Richer SM, Smedema ML, Durkin MM, Herman KM, Hage CA, Fuller D, et al. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis. 2016;62(7):896-902. DOI: 10.1093/cid/ciw007.
          13. Lionakis MS, Holland SM. Human invasive mycoses: immunogenetics on the rise. J Infect Dis. 2015;211(8):1205-7. DOI: 10.1093/infdis/jiu411.
          14. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807-25. DOI: 10.1086/521259.
          15. Pugsley HE, Brown AS, Cheung OT. Chronic cavitary histoplasmosis of the lung. Can Med Assoc J. 1963;88(13):646-9.
          Sistema OJS 3.4.0.7 - Metabiblioteca |